Company Reports Significant Increase in Cash on Hand as a Result of Recent Financings Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical…
Available only in PDF version. Click HERE to open.
Montreal, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of oncology…
Filed pursuant to Rule 424(b)(3)Under the Securities Act of 1933, as amendedRegistration No. 333-264830 Pursuant to this prospectus, the selling stockholders identified herein are offering on a resale basis an…
MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of…
MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of…
Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today…
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments Montreal, Quebec, Canada – (GLOBE NEWSWIRE) – Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the…
For Immediate Release March 14, 2022 MONTREAL, Canada, March 14, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc.(NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceuticalcompany focused on…
For Immediate Release March 10, 2022 MONTREAL, Canada, March 10, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc.(NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceuticalcompany focused on the…